Five-year outcomes in carbon-ion radiotherapy for postoperative pelvic recurrence of rectal cancer: A prospective clinical trial (GUNMA 0801)

Sung, 2021, Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries, CA Cancer J Clin, 71, 209, 10.3322/caac.21660 Kapiteijn, 2001, Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer, N Engl J Med, 345, 638, 10.1056/NEJMoa010580 Wibe, 2004, Oncological outcomes after total mesorectal excision for cure for cancer of the lower rectum: Anterior vs. abdominoperineal resection, Dis Colon Rectum, 47, 48, 10.1007/s10350-003-0012-y You, 2016, Impact of multimodal therapy in locally recurrent rectal cancer, Br J Surg, 103, 753, 10.1002/bjs.10079 Collaborative, 2018, Factors affecting outcomes following pelvic exenteration for locally recurrent rectal cancer, Br J Surg, 105, 650, 10.1002/bjs.10734 Harris, 2016, The outcomes and patterns of treatment failure after surgery for locally recurrent rectal cancer, Ann Surg, 264, 323, 10.1097/SLA.0000000000001524 Kim, 2008, Stereotactic body radiation therapy in patients with pelvic recurrence from rectal carcinoma, Jpn J Clin Oncol, 38, 695, 10.1093/jjco/hyn083 Lee, 2011, Clinical outcomes of chemoradiotherapy for locally recurrent rectal cancer, Radiat Oncol, 6, 51, 10.1186/1748-717X-6-51 Dagoglu, 2015, Stereotactic body radiotherapy (SBRT) reirradiation for pelvic recurrence from colorectal cancer, J Surg Oncol, 111, 478, 10.1002/jso.23858 Johnstone, 2021, A multicentre retrospective review of SABR reirradiation in rectal cancer recurrence, Radiother Oncol, 162, 1, 10.1016/j.radonc.2021.06.030 Shinoto, 2019, Carbon-ion radiotherapy for locally recurrent rectal cancer: Japan Carbon-Ion Radiation Oncology Study Group (J-CROS) Study 1404 Rectum, Radiother Oncol, 132, 236, 10.1016/j.radonc.2018.10.007 Shiba, 2019, Prospective observational study of high-dose carbon-ion radiotherapy for pelvic recurrence of rectal cancer (Gunma 0801), Front Oncol, 9, 702, 10.3389/fonc.2019.00702 Inaniwa, 2015, Reformulation of a clinical-dose system for carbon-ion radiotherapy treatment planning at the National Institute of Radiological Sciences, Japan Phys Med Biol, 60, 3271, 10.1088/0031-9155/60/8/3271 NCI common terminology criteria for adverse events (CTCAE). version 4.0. Data File, http://ctep.cancer.gov/protocolDevelopment/electronic_applications/ctc.htm, [accessed 1 February 2022]. Yamada, 2016, Carbon-ion radiation therapy for pelvic recurrence of rectal cancer, Int J Radiat Oncol Biol Phys, 96, 93, 10.1016/j.ijrobp.2016.04.022 National Comprehensive Cancer Network (NCCN). NCCN guidelines version 3.2017 rectal cancer. Data file, https://www.nccn.org/professionals/physician_gls/pdf/rectal.pdf, [accessed 15 September 2022]; 2017. Hu, 2006, Three-dimensional conformal radiotherapy combined with FOLFOX4 chemotherapy for unresectable recurrent rectal cancer, World J Gastroenterol, 12, 2610, 10.3748/wjg.v12.i16.2610 Sasaki, 2019, First-in-human Phase 1 study of a nonwoven fabric bioabsorbable spacer for particle therapy: Space-making particle therapy (SMPT), Adv Radiat Oncol, 4, 729, 10.1016/j.adro.2019.05.002